McMartin K E, Collins T D, Hewlett T P
J Toxicol Clin Toxicol. 1984;22(2):133-48. doi: 10.3109/15563658408992549.
4-Methylpyrazole (4-MP), a potent competitive inhibitor of alcohol dehydrogenase activity, has potential usefulness as a treatment means for methanol and ethylene glycol poisoning as well as severe disulfiram-ethanol interactions. Further study of the safety and metabolism of 4-MP in human subjects is needed before it can be used in such therapies. An HPLC assay has been developed to measure 4-MP levels in plasma and urine samples. The method was sensitive enough to quantitate 4-MP in an amount as low as 0.1 nmol. Recovery of 4-MP from spiked urine and plasma samples was greater than 90%. 4-MP levels in the plasma and urine of rats injected with an oral dose of 50 mg/kg of body weight were determined; the detectability limit in these samples was about 3 microM. The method is easy to perform and thus has practical application for research laboratories dealing with ethanol metabolism and clinical laboratories desiring to monitor 4-MP levels.
4-甲基吡唑(4-MP)是一种强效的酒精脱氢酶活性竞争性抑制剂,在治疗甲醇和乙二醇中毒以及严重的双硫仑-乙醇相互作用方面具有潜在用途。在将其用于此类治疗之前,需要对人体受试者中4-MP的安全性和代谢进行进一步研究。已开发出一种高效液相色谱法(HPLC)来测量血浆和尿液样本中的4-MP水平。该方法灵敏度足够高,能够定量低至0.1纳摩尔的4-MP。加标尿液和血浆样本中4-MP的回收率大于90%。测定了口服剂量为50毫克/千克体重的大鼠血浆和尿液中的4-MP水平;这些样本中的检测限约为3微摩尔。该方法易于操作,因此对于处理乙醇代谢的研究实验室以及希望监测4-MP水平的临床实验室具有实际应用价值。